Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -84.07%809.47K | 107.44%1.15M | -12.75%-1.37M | -132.90%-9.03M | -34.30%2.62M | 227.20%5.08M | -173.07%-15.52M | -119.47%-1.21M | 654.24%27.45M | 306.70%3.98M |
| Net income from continuing operations | -14.27%-2.42M | -1,093.33%-1.93M | -2.43%-4.75M | -178.98%-31.66M | -2,106.21%-24.75M | 50.32%-2.12M | 94.09%-161.5K | -43.47%-4.64M | -581.01%-11.35M | -106.19%-1.12M |
| Operating gains losses | 175.20%2.19M | 147.72%1.54M | -59.32%-1.37M | 5,781.57%8.66M | 3,904.07%15.66M | -1,374.60%-2.91M | -879.32%-3.23M | -338.69%-861.66K | 99.55%-152.37K | ---411.71K |
| Depreciation and amortization | 6.10%97.6K | -3.62%95.18K | -8.62%99.11K | -20.14%402.76K | 65.99%103.57K | -58.97%91.99K | -9.06%98.75K | -0.68%108.45K | -97.69%504.35K | --62.4K |
| Asset impairment expenditure | ---- | ---- | ---- | 97.78%1.33M | ---- | ---- | ---- | ---- | -91.11%670.01K | --670.01K |
| Remuneration paid in stock | ---- | ---- | ---- | --494.19K | --0 | ---- | ---- | ---- | --0 | --0 |
| Other non cashItems | -2,625.85%-3.66M | 1,491.61%1.42M | 577.22%1.71M | 150.56%3.53M | 176.66%4.12M | 69.27%-134.33K | -261.83%-101.95K | 70.74%-358.51K | 23.23%-6.98M | ---5.38M |
| Change In working capital | -52.52%4.6M | 100.21%25.22K | 261.35%2.95M | -94.57%1.38M | -44.67%5.62M | 3,769.01%9.7M | -352.69%-12.12M | -118.00%-1.83M | 107.63%25.36M | 267.59%10.16M |
| -Change in receivables | -88.85%542.58K | 101.08%69.53K | 93.63%-322.08K | -140.09%-6.84M | 96.95%-232.7K | 2,343.79%4.87M | -171.28%-6.42M | -131.79%-5.05M | 699.59%17.06M | 65.15%-7.62M |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| -Change in prepaid assets | -100.22%-20.76K | 99.64%-34.56K | -100.70%-38.81K | 105.89%306.02K | 1.32%-5.21M | 1,889.21%9.5M | -2,397.82%-9.51M | 27,042.12%5.52M | -663.66%-5.2M | -379.66%-5.28M |
| -Change in payables and accrued expense | 748.89%1.5M | 54.53%1.44M | -71.58%2.25M | 130.97%3.39M | -1,077.44%-5.22M | 86.20%-230.79K | 123.85%930.42K | 234.09%7.91M | -132.77%-10.94M | -96.77%534.22K |
| -Change in other current assets | --0 | --0 | --0 | -98.27%7.06K | 15,863.30%53.98M | -64,868.62%-45.18M | 707,773.13%2.37M | -3,565,641.85%-11.16M | 3,003.57%407.89K | --338.15K |
| -Change in other current liabilities | -94.82%2.12M | -225.27%-913.4K | 10.53%748.18K | -81.39%4.17M | -278.23%-38.15M | 3,023.47%40.91M | 335.92%729.12K | 7,451.17%676.9K | 6,659.43%22.39M | --21.4M |
| -Change in other working capital | 371.55%466.11K | -150.62%-534.12K | 10.92%312.08K | -78.75%346.64K | -42.70%450.06K | -160.72%-171.65K | -156.56%-213.12K | 51.09%281.35K | -85.55%1.63M | --785.43K |
| Tax refund paid | --0 | --0 | --0 | -64.69%6.85M | --529.53K | ---37.41K | -100.03%-6.57K | --6.37M | --19.4M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -84.07%809.47K | 107.44%1.15M | -12.75%-1.37M | -132.90%-9.03M | -34.30%2.62M | 227.20%5.08M | -172.85%-15.52M | -119.67%-1.21M | 654.24%27.45M | 306.70%3.98M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.99%-2.27K | 157.05%18.81K | 95.19%-128.38K | -67.60%-23.5M | 2,863.02%3.1M | -147,789.61%-23.9M | 99.38%-32.97K | 68.98%-2.67M | -1,177.15%-14.02M | -101.86%-112.19K |
| Net PPE purchase and sale | 72.76%-2.27K | 157.05%18.81K | ---128.38K | -204.94%-342.1K | -168.12%-300.79K | 48.42%-8.34K | ---32.97K | --0 | 89.78%-112.19K | -567.68%-112.19K |
| Net business purchase and sale | --0 | --0 | --0 | -242.00%-23.16M | --3.4M | -605.66%-23.89M | --0 | 21.23%-2.67M | ---6.77M | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7.14M | --0 |
| Cash from discontinued investing activities | -5.41M | 0 | ||||||||
| Investing cash flow | 99.99%-2.27K | 156.91%18.81K | 95.19%-128.38K | -106.20%-28.92M | -1,961.96%-2.31M | -147,789.09%-23.9M | 99.38%-33.06K | 68.98%-2.67M | -1,177.15%-14.02M | -101.86%-112.19K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.86%4.8K | 0 | 13.51%355.02K | 769.35%4.2M | -93.59%31K | 3.38M | 481.45K | 312.75K | -16.85%483.42K | -86.79%483.42K |
| Net common stock issuance | --0 | ---- | ---- | -1,476.54%-99.11K | --0 | ---29.92K | ---- | ---- | 100.36%7.2K | --7.2K |
| Proceeds from stock option exercised by employees | -99.86%4.8K | --0 | --0 | 803.30%4.3M | -93.49%31K | --3.41M | --550.64K | --312.75K | -81.67%476.22K | -83.44%476.22K |
| Net other financing activities | --0 | --0 | --355.02K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.86%4.8K | --0 | 13.51%355.02K | 769.35%4.2M | -93.59%31K | --3.38M | --481.45K | --312.75K | -16.85%483.42K | -86.79%483.42K |
| Net cash flow | ||||||||||
| Beginning cash position | -95.87%639.29K | -97.32%826.28K | -97.47%849.18K | 58.90%33.62M | -99.28%218.19K | -53.83%15.49M | 68.46%30.79M | 58.90%33.62M | 32.38%21.16M | 455.97%30.39M |
| Current changes in cash | 105.26%811.99K | 107.78%1.17M | 68.03%-1.14M | -342.58%-33.74M | -92.32%334.56K | -284.96%-15.44M | -194.16%-15.07M | -46.38%-3.57M | 345.45%13.91M | -59.22%4.35M |
| Effect of exchange rate changes | -472.47%-642.5K | -491.87%-1.36M | 53.09%1.12M | 166.97%968.94K | 126.38%296.43K | -80.01%172.5K | 68.85%-229.8K | 262.80%729.81K | -170.47%-1.45M | ---1.12M |
| End cash Position | 270.68%808.78K | -95.87%639.29K | -97.32%826.28K | -97.47%849.18K | -97.47%849.18K | -99.28%218.19K | -53.83%15.49M | 68.46%30.79M | 58.90%33.62M | 110.35%33.62M |
| Free cash from | -84.09%807.19K | 107.54%1.17M | -23.34%-1.5M | -134.29%-9.37M | -40.17%2.32M | 226.99%5.07M | -173.01%-15.55M | -119.67%-1.21M | 975.67%27.34M | 285.80%3.87M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.